# Single and Multiple Dose Safety, Tolerability, PK and Food Effect Study of PAT-1251 in Healthy Adult Subjects

> **NCT02852551** · PHASE1 · COMPLETED · sponsor: **PharmAkea, Inc.** · enrollment: 78 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** PAT-1251
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02852551
- **Lead sponsor:** PharmAkea, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-07
- **Primary completion:** 2016-11
- **Final completion:** 2016-11
- **Target enrollment:** 78 (ACTUAL)
- **Last updated:** 2016-11-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02852551

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02852551, "Single and Multiple Dose Safety, Tolerability, PK and Food Effect Study of PAT-1251 in Healthy Adult Subjects". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02852551. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*